Virginia Retirement Systems Et Al Novavax Inc Transaction History

Virginia Retirement Systems Et Al

$15 Billion
Q3 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Novavax Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 32,563 shares of NVAX stock, worth $273,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,563

Previous 77,663 58.07%

Holding current value

$273,529

Previous $489,000 42.33%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$6.56 - $9.71 $295,856 - $437,921	-45,100 Reduced 58.07%	32,563 $282,000
Q2 2025 Jul 29, 2025	BUY	$5.43 - $7.74 $249,780 - $356,040	46,000 Added 145.28%	77,663 $489,000
Q1 2025 Jul 16, 2025	SELL	$6.41 - $10.82 $734,182 - $1.24 Million	-114,537 Reduced 78.34%	31,663 $202,000
Q3 2023 Jan 02, 2024	BUY	$6.81 - $9.74 $124,623 - $178,242	18,300 Added 14.31%	146,200 $1.06 Million
Q2 2023 Aug 22, 2023	BUY	$6.67 - $9.52 $305,486 - $436,016	45,800 Added 55.79%	127,900 $950,000
Q1 2023 Jul 11, 2023	BUY	$5.76 - $12.48 $201,600 - $436,800	35,000 Added 74.31%	82,100 $568,000
Q4 2022 May 17, 2023	BUY	$8.86 - $25.04 $268,458 - $758,712	30,300 Added 180.36%	47,100 $484 Million
Q3 2022 May 16, 2023	BUY	$18.2 - $76.12 $305,760 - $1.28 Million	16,800 New	16,800 $306 Million
Q2 2021 Aug 13, 2021	SELL	$121.0 - $257.67 $1.1 Million - $2.34 Million	-9,100 Closed	0 $0
Q1 2021 Apr 30, 2021	SELL	$112.98 - $319.93 $350,238 - $991,783	-3,100 Reduced 25.41%	9,100 $1.65 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $141,732 - $251,100	1,800 Added 17.31%	12,200 $1.36 Million
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $150,936 - $339,169	1,900 Added 22.35%	10,400 $1.13 Million
Q2 2020 Aug 12, 2020	BUY	$13.86 - $83.61 $117,810 - $710,685	8,500 New	8,500 $708,000

Others Institutions Holding NVAX

# of Institutions

308

Shares Held

94.2M

Call Options Held

6.11M

Put Options Held

10.7M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $657M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Novavax Inc Transaction History